Nanoparticles for the induction of antigen-specific Tregs

Immunotherapy

Volumn 5, Issue 5, 2013, Pages 437-440

  Quintana, Francisco J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

multiple sclerosis; nanoparticles; therapy; Tregs; Type 1 diabetes

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; COLLOIDAL GOLD; NANOPARTICLE; TRANSCRIPTION FACTOR;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL EXPANSION; DENDRITIC CELL; DRUG DEGRADATION; DRUG HALF LIFE; IMMUNOLOGICAL TOLERANCE; MEMORY T LYMPHOCYTE; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; REVIEW;

ANTIGENS; AUTOIMMUNE DISEASES; DIABETES MELLITUS, TYPE 1; HUMANS; LYMPHOCYTE ACTIVATION; MULTIPLE SCLEROSIS; NANOPARTICLES; NANOTECHNOLOGY; T-LYMPHOCYTES, REGULATORY;

EID: 84877267689     PISSN: 1750743X     EISSN: 17507448     Source Type: Journal    
DOI: 10.2217/imt.13.25     Document Type: Review

References (24)

1. Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 10(7), 490-500 (2010).
2. Cvetanovich GL, Hafler DA. Human regulatory T cells in autoimmune diseases. Curr. Opin. Immunol. 22(6), 753-760 (2010).
3. Sanvicens N, Marco MP. Multifunctional nanoparticles - properties and prospects for their use in human medicine. Trends Biotechnol. 26(8), 425-433 (2008).
4. Tsai S, Shameli A, Yamanouchi J et al. Reversal of autoimmunity by boosting memory-like autoregulatory T cells. Immunity 32(4), 568-580 (2010).
5. Vanderlugt CL, Miller SD. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat. Rev. Immunol. 2(2), 85-95 (2002).
6. Getts DR, Turley DM, Smith CE et al. Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells. J. Immunol. 187(5), 2405-2417 (2011).
7. Getts DR, Martin AJ, Mccarthy DP et al. Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis. Nat. Biotechnol. 30(12), 1217-1224 (2012).
8. Quintana FJ, Farez MF, Viglietta V et al. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc. Natl Acad. Sci. USA 105(48), 18889-18894 (2008).
9. Quintana FJ. The aryl hydrocarbon receptor: a molecular pathway for the environmental control of the immune response. Immunology 138(3), 183-189 (2013).
10. Apetoh L, Quintana FJ, Pot C et al. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat. Immunol. 11(9), 854-861 (2010).
11. Gandhi R, Kumar D, Burns EJ et al. Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells. Nat. Immunol. 11(9), 846-853 (2010).
12. Quintana FJ, Basso AS, Iglesias AH et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453, 65-71 (2008).
13. Quintana FJ, Jin H, Burns EJ et al. Aiolos promotes T(H)17 differentiation by directly silencing Il2 expression. Nat. Immunol. 13(8), 770-777 (2012).
14. Quintana FJ, Murugaiyan G, Farez MF et al. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis. Proc. Natl Acad. Sci. USA 107(48), 20768-20773 (2010).
15. Wu HY, Quintana FJ, Da Cunha AP et al. In vivo induction of Tr1 cells via mucosal dendritic cells and AHR signaling. PLoS ONE 6(8), e23618 (2011).
16. Yeste A, Nadeau M, Burns EJ, Weiner HL, Quintana FJ. Nanoparticle- mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis. Proc. Natl Acad. Sci. USA 109(28), 11270-11275 (2012).
17. Hauben E, Gregori S, Draghici E et al. Activation of the aryl hydrocarbon receptor promotes allograft-specific tolerance through direct and dendritic cell-mediated effects on regulatory T cells. Blood 112(4), 1214-1222 (2008).
18. Mezrich JD, Fechner JH, Zhang X, Johnson BP, Burlingham WJ, Bradfield CA. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J. Immunol. 185(6), 3190-3198 (2010).
19. Nguyen NT, Kimura A, Nakahama T et al. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc. Natl Acad. Sci. USA 107(46), 19961-19966 (2010).
20. Nguyen LP, Bradfield CA. The search for endogenous activators of the aryl hydrocarbon receptor. Chem. Res. Toxicol. 21(1), 102-116 (2008).
21. Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4(10), 762-774 (2004).
22. Opitz CA, Litzenburger UM, Sahm F et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478(7368), 197-203 (2011).
23. Hall JA, Grainger JR, Spencer SP, Belkaid Y. The role of retinoic acid in tolerance and immunity. Immunity 35(1), 13-22 (2011).
24. Paciotti GF, Myer L, Weinreich D et al. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv. 11(3), 169-183 (2004).